SKI Market

Indian Indices

Nifty

25,114.00 108.50
(0.43%)

Sensex

81,904.70 355.97
( 0.44%)

Bank Nifty

54,809.30 139.70
( 0.26%)

Nifty IT

36,110.75 107.30
( 0.30%)

Global Indices

Nasdaq

45,857.35 271.66
(-0.59%)

Dow Jones

6,605.38 -3.09
(-0.05%)

Hang Seng

44,778.02 405.52
(0.91%)

Nikkei 225

9,283.29 -14.29
(-0.15%)

Forex

USD-INR

88.28 0.18
(0.20%)

EUR-INR

103.39 0.27
(0.26%)

GBP-INR

119.55 0.32
(0.27%)

JPY-INR

0.60 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

345.7513641

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

15.94

109867.7

EPS(TTM)

Face Value()

Div & Yield %

82.59

0.61

Back

NCL Research and Financial Services reports standalone net profit of Rs 1.70 crore in the June 2025 quarter

Aug 13,2025

Net profit of NCL Research and Financial Services reported to Rs 1.70 crore in the quarter ended June 2025 as against net loss of Rs 2.16 crore during the previous quarter ended June 2024. Sales rose 31.88% to Rs 1.82 crore in the quarter ended June 2025 as against Rs 1.38 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	1.82	1.38	32
OPM %	82.42	-189.86	-
PBDT	2.28	-1.73	LP
PBT	2.27	-1.74	LP
NP	1.70	-2.16	LP

25,114.00 108.50 (0.43%)

81,904.70 355.97 ( 0.44%)

54,809.30 139.70 ( 0.26%)

36,110.75 107.30 ( 0.30%)

45,857.35 271.66 (-0.59%)

6,605.38 -3.09 (-0.05%)

44,778.02 405.52 (0.91%)

9,283.29 -14.29 (-0.15%)

88.28 0.18 (0.20%)

103.39 0.27 (0.26%)

119.55 0.32 (0.27%)

0.60 0.00 (0.17%)